Objectives:
Many reports exist of the cardiovascular toxicity of smoked cannabis but none of arterial stiffness measures or vascular age (VA). In view of its diverse toxicology, the possibility that cannabis-exposed patients may be ageing more quickly requires investigation.
Design:
Cross-sectional and longitudinal, observational. Prospective.
Setting:
Single primary care addiction clinic in Brisbane, Australia.
Participants:
11 cannabis-only smokers, 504 tobacco-only smokers, 114 tobacco and cannabis smokers and 534 non-smokers.
Exclusions:
known cardiovascular disease or therapy or acute exposure to alcohol, amphetamine, heroin or methadone.
Intervention:
Radial arterial pulse wave tonometry (AtCor, SphygmoCor, Sydney) performed opportunistically and sequentially on patients between 2006 and 2011.
Main Outcome Measure:
Algorithmically calculated VA.
Secondary Outcomes:
other central haemodynamic variables.
Results:
Differences between group chronological ages (CA, 30.47±0.48 to 40.36±2.44, mean±SEM) were controlled with linear regression. Between-group sex differences were controlled by single-sex analysis. Mean cannabis exposure among patients was 37.67±7.16 g-years. In regression models controlling for CA, Body Mass Index (BMI), time and inhalant group, the effect of cannabis use on VA was significant in males (p=0.0156) and females (p=0.0084). The effect size in males was 11.84%. A dose-response relationship was demonstrated with lifetime exposure (p<0.002) additional to that of tobacco and opioids. In both sexes, the effect of cannabis was robust to adjustment and was unrelated to its acute effects. Significant power interactions between cannabis exposure and the square and cube of CA were demonstrated (from p<0.002).
Conclusions:
Cannabis is an interactive cardiovascular risk factor (additional to tobacco and opioids), shows a prominent dose-response effect and is robust to adjustment. Cannabis use is associated with an acceleration of the cardiovascular age, which is a powerful surrogate for the organismal-biological age. This likely underlies and bi-directionally interacts with its diverse toxicological profile and is of considerable public health and regulatory importance.
Citing Articles
Acute Effects of Cannabis Inhalation on Arterial Stiffness, Vascular Endothelial Function, and Cardiac Function.
Cheung C, Coates A, Baker R, Burr J
J Am Heart Assoc. 2024; 13(23):e037731.
PMID: 39575727
PMC: 11681564.
DOI: 10.1161/JAHA.124.037731.
Key insights into cannabis-cancer pathobiology and genotoxicity.
Reece A, Hulse G
Addict Biol. 2024; 29(11):e70003.
PMID: 39538372
PMC: 11560801.
DOI: 10.1111/adb.70003.
Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome.
Reece A, Hulse G
Front Psychiatry. 2023; 14:1182536.
PMID: 37854446
PMC: 10579598.
DOI: 10.3389/fpsyt.2023.1182536.
Cannabis and Other Substance Misuse: Implications and Regulations.
Khairinisa M, Alfaqeeh M, Rafif S, Muljono F, Colin M
Toxics. 2023; 11(9).
PMID: 37755766
PMC: 10534492.
DOI: 10.3390/toxics11090756.
Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics.
Reece A, Hulse G
Front Psychiatry. 2023; 14:1182535.
PMID: 37732074
PMC: 10507876.
DOI: 10.3389/fpsyt.2023.1182535.
Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study.
Reece A, Bennett K, Hulse G
J Xenobiot. 2023; 13(3):323-385.
PMID: 37489337
PMC: 10366890.
DOI: 10.3390/jox13030024.
Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration.
Reece A, Hulse G
Int J Environ Res Public Health. 2023; 20(4).
PMID: 36834053
PMC: 9967951.
DOI: 10.3390/ijerph20043360.
Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis.
Reece A, Hulse G
Int J Environ Res Public Health. 2022; 19(24).
PMID: 36554603
PMC: 9778714.
DOI: 10.3390/ijerph192416721.
Epidemiological Patterns of Cannabis- and Substance- Related Congenital Uronephrological Anomalies in Europe: Geospatiotemporal and Causal Inferential Study.
Reece A, Hulse G
Int J Environ Res Public Health. 2022; 19(21).
PMID: 36360648
PMC: 9657099.
DOI: 10.3390/ijerph192113769.
Preparedness for healthy ageing and polysubstance use in long-term cannabis users: a population-representative longitudinal study.
Meier M, Caspi A, Ambler A, Hariri A, Harrington H, Hogan S
Lancet Healthy Longev. 2022; 3(10):e703-e714.
PMID: 36202130
PMC: 9552770.
DOI: 10.1016/S2666-7568(22)00201-X.
Lifestyle Choices and Risk of Developing Cardiovascular Disease in College Students.
Tran D, Silvestri-Elmore A, Sojobi A
Int J Exerc Sci. 2022; 15(2):808-819.
PMID: 35992186
PMC: 9362881.
DOI: 10.70252/YWOV6377.
Effects of cannabis on congenital limb anomalies in 14 European nations: A geospatiotemporal and causal inferential study.
Reece A, Hulse G
Environ Epigenet. 2022; 8(1):dvac016.
PMID: 35966826
PMC: 9364687.
DOI: 10.1093/eep/dvac016.
European Epidemiological Patterns of Cannabis- and Substance-Related Body Wall Congenital Anomalies: Geospatiotemporal and Causal Inferential Study.
Reece A, Hulse G
Int J Environ Res Public Health. 2022; 19(15).
PMID: 35897396
PMC: 9330494.
DOI: 10.3390/ijerph19159027.
Congenital anomaly epidemiological correlates of Δ8THC across USA 2003-16: panel regression and causal inferential study.
Reece A, Hulse G
Environ Epigenet. 2022; 8(1):dvac012.
PMID: 35782486
PMC: 9245652.
DOI: 10.1093/eep/dvac012.
Geospatiotemporal and causal inference study of cannabis and other drugs as risk factors for female breast cancer USA 2003-2017.
Reece A, Hulse G
Environ Epigenet. 2022; 8(1):dvac006.
PMID: 35386387
PMC: 8978645.
DOI: 10.1093/eep/dvac006.
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding....
Reece A, Hulse G
Arch Public Health. 2022; 80(1):101.
PMID: 35354499
PMC: 8969240.
DOI: 10.1186/s13690-022-00813-6.
Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions.
Reece A, Hulse G
Arch Public Health. 2022; 80(1):100.
PMID: 35354495
PMC: 8969377.
DOI: 10.1186/s13690-022-00812-7.
Lifetime marijuana use and epigenetic age acceleration: A 17-year prospective examination.
Allen J, Danoff J, Costello M, Hunt G, Hellwig A, Krol K
Drug Alcohol Depend. 2022; 233:109363.
PMID: 35231715
PMC: 8982677.
DOI: 10.1016/j.drugalcdep.2022.109363.
Cannabinoid and substance relationships of European congenital anomaly patterns: a space-time panel regression and causal inferential study.
Reece A, Hulse G
Environ Epigenet. 2022; 8(1):dvab015.
PMID: 35145760
PMC: 8824558.
DOI: 10.1093/eep/dvab015.
Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015.
Reece A, Hulse G
BMC Pediatr. 2022; 22(1):47.
PMID: 35042455
PMC: 8767720.
DOI: 10.1186/s12887-021-02996-3.